-
Novartis Pharmaceuticals Corporation et al v. West-Ward Pharmaceuticals International Limited DC CAFC
- 1:15-cv-00474
- D. Del.
- Judge: Richard G. Andrews
- Filed: 06/10/2015
- Closed: 12/21/2017
- Latest Docket Entry: 06/09/2020
- PACER
- Docket updated daily
2
Plaintiffs
1
Defendant
0
Accused
Products
2
Patents-in-Suit
926
Days in
Litigation
-
Novartis Pharmaceuticals Corporation et al v. West-Ward Pharmaceuticals International Limited DC CAFC
- 1:15-cv-00474
- D. Del.
- Judge: Richard G. Andrews
- Filed: 06/10/2015
- Closed: 12/21/2017
- Latest Docket Entry: 06/09/2020
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for inhibiting growth of solid excretory system tumors in a subject, said method consisting of administering to said subject a therapeutically effective amount of a compound of formula I <chemistry id="CHEM-US-00002" num="00002"><img
view more
|
Valid (103)
Entry 103 Entry 100 |
2 |
The method of claim 1 wherein the solid excretory system tumor is an advanced solid excretory system tumor.
|
Valid (103)
Entry 103 Entry 100 |
3 |
The method of claim 1 wherein the solid excretory system tumor is a kidney tumor.
|
Valid (103)
Entry 103 Entry 100 |
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for treating pancreatic neuroendocrine tumors, comprising administering to a human subject in need thereof a therapeutically effective amount of 40-O-(2-hydroxyethyl)-rapamycin as a monotherapy and wherein the tumors are advanced tumors
view more
|
Valid (103)
Entry 103 Entry 100 |
2 |
The method of claim 1, wherein a unit dose of 40-O-(2-hydroxyethyl)-rapamycin is 10 mg/day.
|
Valid (103)
Entry 103 |
-
Infringement
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Everolimus tablet 10 mgEverolimus tablet 2.5 mgEverolimus tablet 5.0Everolimus tablet 7.5 | US 8,410,131 B2 |
1, 2, 3
|
Infringement
Entry 103
|
Everolimus tablet 10 mgEverolimus tablet 2.5 mgEverolimus tablet 5.0Everolimus tablet 7.5 | US 9,006,224 B2 |
1
|
Infringement
Entry 103
|